ATE367168T1 - Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon - Google Patents

Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon

Info

Publication number
ATE367168T1
ATE367168T1 AT01920006T AT01920006T ATE367168T1 AT E367168 T1 ATE367168 T1 AT E367168T1 AT 01920006 T AT01920006 T AT 01920006T AT 01920006 T AT01920006 T AT 01920006T AT E367168 T1 ATE367168 T1 AT E367168T1
Authority
AT
Austria
Prior art keywords
treatment
schaemia
hypoxya
interferon
beta
Prior art date
Application number
AT01920006T
Other languages
English (en)
Inventor
Wouter Veldhuis
Der Meide Petrus Van
Klaas Nicolay
Original Assignee
Cytech B V U
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytech B V U filed Critical Cytech B V U
Application granted granted Critical
Publication of ATE367168T1 publication Critical patent/ATE367168T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01920006T 2001-04-03 2001-04-03 Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon ATE367168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2001/000276 WO2002080959A1 (en) 2001-04-03 2001-04-03 Method of treatment of hypoxia/ischaemia blutflusswiderstand

Publications (1)

Publication Number Publication Date
ATE367168T1 true ATE367168T1 (de) 2007-08-15

Family

ID=19760746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01920006T ATE367168T1 (de) 2001-04-03 2001-04-03 Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon

Country Status (6)

Country Link
US (2) US20040105843A1 (de)
EP (2) EP1372702B1 (de)
AT (1) ATE367168T1 (de)
AU (1) AU2002249692A1 (de)
DE (1) DE60129472T2 (de)
WO (2) WO2002080959A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008798A (es) * 2002-03-12 2004-11-26 Maxygen Aps Moleculas semejantes a interferon beta para el tratamiento de evento cerebrovascular.
JP4613065B2 (ja) * 2002-08-27 2011-01-12 ケネディー クリーガー インスティチュート 微小血管の血液容量の磁気共鳴画像化
WO2004084933A1 (en) * 2003-03-28 2004-10-07 Faron Pharmaceuticals Oy Elevation of adenosine level by cytokine-induced expression of cd73
FI20030467A0 (fi) * 2003-03-28 2003-03-28 Sirpa Jalkanen Menetelmä tulehdustilojen hoitamiseen
FI20051003A0 (fi) * 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy Menetelmä iskemiareperfuusiovaurion tai monielinhäiriön hoitamiseksi tai estämiseksi
EP2813144A1 (de) 2006-10-09 2014-12-17 Charleston Laboratories, Inc. Analgetische Zusammensetzungen enthaltend ein Antihistamin
EP2076533B1 (de) 2007-05-02 2014-10-08 Ambrx, Inc. Modifizierte interferon-beta-polypeptide und ihre verwendungen
EP3090743A1 (de) 2008-01-09 2016-11-09 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
EP3423041A4 (de) 2016-03-04 2019-09-11 Charleston Laboratories, Inc. Pharmazeutische zusammensetzungen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0797998A4 (de) * 1995-11-17 2003-01-15 Toray Industries Schutz für endothelzellen
JPH09151137A (ja) * 1995-12-01 1997-06-10 Toray Ind Inc 平滑筋細胞増殖抑制剤

Also Published As

Publication number Publication date
EP1372702B1 (de) 2007-07-18
DE60129472T2 (de) 2008-04-17
DE60129472D1 (de) 2007-08-30
WO2002080953A3 (en) 2002-12-12
US20040136957A1 (en) 2004-07-15
AU2002249692A1 (en) 2002-10-21
EP1377303A2 (de) 2004-01-07
US20040105843A1 (en) 2004-06-03
EP1372702A1 (de) 2004-01-02
WO2002080959A1 (en) 2002-10-17
WO2002080953A2 (en) 2002-10-17

Similar Documents

Publication Publication Date Title
DE60129472D1 (de) Behandlung von hypoxya/ischaemia blutflusswiderstand mit beta-interferon
ES2187798T3 (es) Procedimiento de conservacion de virus recombinantes infecciosos, suspension acuosa viral y su utilizacion como medicamento.
DE60042736D1 (de) Blutfilter zur behandlung von gefässerkrankungen
DE69923291D1 (de) Elektrochirurgische vorrichtung zur behandlung von schliessmuskeln
EA200500646A1 (ru) Фармацевтическая комбинация для лечения повреждений тканей, вызванных недостаточностью артериального кровотока
WO2006017470A3 (en) Device and method for treating a vessel
RU2010153688A (ru) Режим дозирования телапревира
PARK et al. Recanalization of embolized cavernosal artery: restoring potency in the patient with high flow priapism
DE60022499D1 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
EA200100785A1 (ru) Шипучие слабительные средства
Obermaier et al. Exogenous and endogenous nitric oxide donors improve post-ischemic tissue oxygenation in early pancreatic ischemia/reperfusion injury in the rat
Blendis et al. Stopping the unstoppable?
Takano et al. Nitric oxide inhalation as an effective therapy for acute respiratory distress syndrome due to near-drowning: a case report
Chen et al. Long-term follow-up study and comparison of meso-atrial shunts and meso-cavo-atrial shunts for treatment of combined Budd-Chiari syndrome
DE60125377D1 (de) Behandlung von hepatitis c mit thymosin, interferon und ribavirin
Dapkutė et al. Erenumab effectiveness and safety: comparison of real-life data and clinical trial results
DE50015051D1 (de) Mittel zum verschluss von blutgefässen
RU2001115079A (ru) Способ лечения секреторных форм мужского бесплодия
Nakata et al. Surgical treatment of peripheral congenital vascular dysplasia
CN204318984U (zh) 一种防止阴囊滑出的阴囊托带裤
Verbeke et al. Acute traumatic arteriovenous fistula following blunt trauma of the wrist
RU98117264A (ru) Способ инактивации вируса иммунодефицита человека и других вирусов в плазме крови человека с сохранением функциональной активности белков плазмы крови
Blaney Experimental HIV drugs may improve prevention
Castedal et al. Combination therapy of interferon alpha-2b and ribavirin for recurrent hepatitis C after liver transplantation
RU2004113002A (ru) Способ лечения заболеваний периферических кровеносных сосудов

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties